CA964953A - Nebulizer and tent assembly - Google Patents

Nebulizer and tent assembly

Info

Publication number
CA964953A
CA964953A CA123,720A CA123720A CA964953A CA 964953 A CA964953 A CA 964953A CA 123720 A CA123720 A CA 123720A CA 964953 A CA964953 A CA 964953A
Authority
CA
Canada
Prior art keywords
nebulizer
tent assembly
tent
assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA123,720A
Other versions
CA123720S (en
Inventor
Ted A. Dixon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA964953A publication Critical patent/CA964953A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G10/00—Treatment rooms or enclosures for medical purposes
    • A61G10/04—Oxygen tents ; Oxygen hoods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/909—Breathing apparatus with means for preventing patient cross-contamination
CA123,720A 1970-12-31 1971-09-27 Nebulizer and tent assembly Expired CA964953A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10310170A 1970-12-31 1970-12-31

Publications (1)

Publication Number Publication Date
CA964953A true CA964953A (en) 1975-03-25

Family

ID=22293409

Family Applications (1)

Application Number Title Priority Date Filing Date
CA123,720A Expired CA964953A (en) 1970-12-31 1971-09-27 Nebulizer and tent assembly

Country Status (2)

Country Link
US (1) US3703173A (en)
CA (1) CA964953A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004917A1 (en) * 1987-01-09 1988-07-14 The Beth Israel Hospital Association An isolation, sterilization and maximum observation tent
US5725426A (en) * 1995-12-26 1998-03-10 Alvarez; Henry Portable and disposable sterilized operating environment

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843445A (en) * 1987-06-24 1998-12-01 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Pharmaceutical oral, enteral or by-inhalation dosage form for suppressing an autoimmune response associated with type i diabetes
US5245998A (en) * 1991-11-15 1993-09-21 Pep, Inc. Humidity concentrating tent
US5372126A (en) * 1992-09-14 1994-12-13 Blau; Anthony D. Pulmonary sampling chamber
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US7448375B2 (en) 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
WO1995020413A1 (en) * 1994-01-31 1995-08-03 Blau Anthony D Pulmonary sampling chamber and method
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd Immunological and oral tolerance-inducing composition and use thereof for the prevention and/or for the treatment of atherosclerosis
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6878749B2 (en) * 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
CO5200844A1 (en) 1999-09-17 2002-09-27 Novartis Ag A COMBINATION THAT INCLUDES NATEGLINED AND WHEN AT LEAST ANOTHER ANTI-DIABETIC COMPOUND USED FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR OF A DISEASE OR CONDITION ASSOCIATED WITH DIBETES
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
DE60030323T2 (en) * 1999-12-24 2007-10-11 Genentech, Inc., South San Francisco METHOD AND CONNECTIONS FOR EXTENDING THE HALF-TIME PERIODS FOR THE DISPOSAL OF BIOWIRESAMIC COMPOUNDS
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
EP1757701A1 (en) 1999-12-24 2007-02-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
AU2001249214A1 (en) 2000-03-15 2001-09-24 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
JP4986361B2 (en) 2000-05-24 2012-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Stroke prevention method by induction of tolerance to E-selectin
US6927223B1 (en) 2000-05-26 2005-08-09 Washington State University Research Foundation Use of serotonin agents for adjunct therapy in the treatment of cancer
CA2476410C (en) 2002-03-01 2013-09-24 Celltech R & D, Inc. Methods to increase or decrease bone density
WO2004004702A2 (en) 2002-07-09 2004-01-15 The Scripps Research Institute Method to inhibit ischemia and reperfusion injury
US20040065361A1 (en) * 2002-10-08 2004-04-08 Pratt Michael James Foldable bed tent
WO2004045531A2 (en) * 2002-11-14 2004-06-03 Cornell Research Foundation, Inc. Protection of cardiac myocardium
DE60334246D1 (en) 2002-11-21 2010-10-28 Celltech R & D Inc MODULATE IMMUNE RESPONSES
US20050053612A1 (en) * 2003-08-20 2005-03-10 Granstein Richard D. Nucleotide regulation of immune responses
WO2005023830A2 (en) * 2003-09-05 2005-03-17 The Scripps Research Institute Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
WO2005023831A1 (en) * 2003-09-05 2005-03-17 The Scripps Research Institute Detection of cholesterol ozonation products
WO2005037317A2 (en) * 2003-10-17 2005-04-28 Cornell Research Foundation, Inc. Mast cell-derived renin
US7164008B2 (en) * 2003-11-17 2007-01-16 University Of Iowa Research Foundation Isolated complexes of endotoxin and MD-2
JP2007527539A (en) * 2004-03-05 2007-09-27 ザ スクリプス リサーチ インスティテュート High-throughput glycan microarray
CA2573821A1 (en) 2004-07-16 2006-01-26 Pfizer Products Inc. Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
PT1778720E (en) 2004-08-18 2010-11-29 Novabiotics Ltd Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
WO2006041641A2 (en) * 2004-10-05 2006-04-20 Genentech, Inc. Therapeutic agents with decreased toxicity
WO2006068758A2 (en) * 2004-11-19 2006-06-29 The Scripps Research Institute Detection, prevention and treatment of breast cancer
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
US7413729B2 (en) * 2005-01-13 2008-08-19 University Of Iowa Research Foundation Sialic acid permease system
US20060194740A1 (en) * 2005-02-25 2006-08-31 Ulevitch Richard J NOD1 as an anti-tumor agent
WO2006109312A2 (en) * 2005-04-15 2006-10-19 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
WO2006128025A2 (en) * 2005-05-23 2006-11-30 Children's Hospital Medical Center Regulatory proteins in lung repair and treatment of lung disease
US8088396B2 (en) * 2006-03-01 2012-01-03 University Of Iowa Research Foundation Isolated complexes of endotoxin and modified MD-2
US20070265170A1 (en) * 2006-05-15 2007-11-15 Ola Blixt Detection, prevention and treatment of ovarian cancer
WO2008036838A2 (en) * 2006-09-20 2008-03-27 University Of Iowa Research Foundation Isolated complexes of covalently cross-linked endotoxin and modified md-2
WO2009089027A1 (en) * 2008-01-09 2009-07-16 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Service, National Institutes Of Health Phosphodiesterase inhibitors
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
WO2010047829A1 (en) 2008-10-24 2010-04-29 The Scripps Research Institute Mutant hepatitis c virus e2 polypeptides for hcv treatment
GB201016733D0 (en) 2010-10-05 2010-11-17 Novabiotics Ltd Compounds and their use
WO2012076842A1 (en) 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
WO2013013178A1 (en) 2011-07-21 2013-01-24 Kansas State University Research Foundation Sesquiterpenes for antifungal applications
US20150026892A1 (en) * 2013-07-28 2015-01-29 Dante DeFranco, JR. Humidity and Allergy Control Device
WO2016056033A1 (en) * 2014-10-08 2016-04-14 Roberto Monterenzi Method and device for the dispensation of mists for therapeutic use
CA2998840C (en) 2015-09-22 2018-12-04 Blu Room Enterprises, LLC Apparatus for providing light therapy
US10994006B2 (en) 2016-07-08 2021-05-04 The Scripps Research Institute Desensitizing mast cells by co-presentation of antigens with high affinity mast cell siglec ligands
US10548764B2 (en) * 2016-08-22 2020-02-04 MAZ Medical LLC Cooling bed system
WO2021086958A1 (en) 2019-10-28 2021-05-06 The Scripps Research Institute Immune cell receptor antibodies conjugated to high affinity siglec-ligands
US11813202B1 (en) * 2020-04-14 2023-11-14 Janice McLean CPAP enclosure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2131103A (en) * 1936-01-17 1938-09-27 Ohio Chemical And Mfg Company Control for therapeutic air conditioners
FR973081A (en) * 1948-10-07 1951-02-07 Device intended for therapy by gases or vapors, and in particular for oxygen therapy
US3540446A (en) * 1968-07-02 1970-11-17 Ted A Dixon Oxygen tent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004917A1 (en) * 1987-01-09 1988-07-14 The Beth Israel Hospital Association An isolation, sterilization and maximum observation tent
US5725426A (en) * 1995-12-26 1998-03-10 Alvarez; Henry Portable and disposable sterilized operating environment

Also Published As

Publication number Publication date
US3703173A (en) 1972-11-21

Similar Documents

Publication Publication Date Title
CA964953A (en) Nebulizer and tent assembly
CA927874A (en) Structural assembly and clip
CA982577A (en) Diamino and dinitro-s-triazines
CA949280A (en) Building system and components therefor
CA965328A (en) Ventilator
CA928363A (en) Nebulizer
CA940685A (en) Building assembly and components
CA995670A (en) Phenanthrolines and pyrido-quinolines
CA953898A (en) Dryshaver construction and operation
CA946797A (en) Coupler-aspirator-valve assembly
CA983935A (en) 2-phenyl-3-acylbenzothiazolines and their oxides
CA972286A (en) Humidifier assembly
CA951615A (en) Poppett and valve assembly
CA994942A (en) Polyhydroxamides and polyurethanes therefrom
AU2579071A (en) New dimethyl-dichlorovinylphosphate-base insecticide and its application
CA834014A (en) Shelter construction and fasteners therefor
CA883064A (en) Umbrella tent
CA851486A (en) Structural element and assembly
CA871492A (en) Sunbathing shelter
CA834145A (en) Germaniding and tiniding
CA858851A (en) Ventilator structure
AU422768B2 (en) Semi-trailers and low-loaders
CA848222A (en) Blower assembly and mounting means
CA857057A (en) Structural assembly and clip
CA842232A (en) Dihydrodecoyinines and processes